Skip to main content
logo
  • Insights

      Liquidity Insights

      • Liquidity Insights Overview
      • Global Liquidity Investment Outlook
      • Tokenization
      • Case Studies
      • Partnership with fintechs
      • ESG Resources for Liquidity Investors
      • Leveraging the Power of Cash Segmentation
      • Cash Investment Policy Statement

      Market Insights

      • Market Insights Overview
      • Eye on the Market
      • Guide to the Markets

      Portfolio Insights

      • Portfolio Insights Overview
      • Currency
      • Fixed Income
      • Long-Term Capital Market Assumptions
      • Strategic Investment Advisory Group
    • Resources
        • MORGAN MONEY
        • Global Liquidity Investment Academy
      • About us
          • Our Leadership Team
          • Diversity, Opportunity & Inclusion
        • Contact us
        • LIQUIDITY INVESTORS
          • INSTITUTIONAL INVESTORS
        You are about to leave the site Close
        J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
        CONTINUE Go Back
        1. Blinded by science

        • LinkedIn Twitter Facebook WhatsApp

        Blinded by science

        07/07/2020

        Michael Cembalest

         

        Prospects for further US employment and profits growth are improving, but the US is now running the 3rd highest infection rate in the world.  In infection hotspot states, governors are relying on falling mortality as the reason to make only minor policy adjustments.  This week, we look at why mortality is diverging from infections and hospitalizations, and more broadly, at whether a US scientific trust gap has played a role in the recent infection surge.  To conclude: some client Q&A on last week’s Eye on the Market energy paper. 

        Continue reading

        07/07/2020

        Listen to the audio file or subscribe to the podcast to get the latest updates.

        LISTEN AND SUBSCRIBE TO MICHAEL CEMBALEST

        In this podcast series, Michael Cembalest, Chairman of Market and Investment Strategy offers timely commentary on the economy, marekts and investment portfolios
         

        Listen on Apple Podcasts

         

        Listen on Google Play

        Subscribe to RSS Feed

        Read more by michael cembalest
        J.P. Morgan Asset Management

        • Investment stewardship
        • About us
        • Contact us
        • Privacy policy
        • Cookie policy
        • Sitemap
        J.P. Morgan

        • J.P. Morgan
        • JPMorgan Chase
        • Chase

        READ IMPORTANT LEGAL INFORMATION. CLICK HERE >

        The value of investments may go down as well as up and investors may not get back the full amount invested.

        Copyright 2026 JPMorgan Chase & Co. All rights reserved.